BiotechTube

pudexacianinium chloride

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Intraoperative Ureter Visualization

Conditions

Intraoperative Ureter Visualization, Abdominolpelvic Surgery

Trial Timeline

Aug 2, 2023 → Jan 16, 2025

NCT ID
NCT05754333

About pudexacianinium chloride

pudexacianinium chloride is a phase 3 stage product being developed by Astellas Pharma for Intraoperative Ureter Visualization. The current trial status is completed. This product is registered under clinical trial identifier NCT05754333. Target conditions include Intraoperative Ureter Visualization, Abdominolpelvic Surgery.

What happened to similar drugs?

1 of 2 similar drugs in Intraoperative Ureter Visualization were approved

Approved (1) Terminated (0) Active (1)
✅FlosealBaxterApproved
🔄pudexacianinium chlorideAstellas PharmaPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (5)

NCT IDPhaseStatus
NCT05999747Phase 3Completed
NCT05754333Phase 3Completed
NCT05495581Phase 1Completed
NCT05457842Phase 2Terminated
NCT04238481Phase 2Completed

Competing Products

3 competing products in Intraoperative Ureter Visualization

See all competitors
ProductCompanyStageHype Score
pudexacianinium chlorideAstellas PharmaPhase 3
40
RocuroniumMerckPre-clinical
26
FlosealBaxterApproved
40